Decera Clinical Education Pharmacy Practice Podcast

ProCE
  • 5.0 (1)
  • COURSES

Enhance your pharmacy practice with ProCE’s up-to-date, clinically relevant, and evidence-based education across a variety of therapeutic areas.

  1. Available and Emerging Subcutaneous Immunotherapy Treatment Options for Patients With Cancer: A Pharmacy Perspective

    08/12/2025

    Available and Emerging Subcutaneous Immunotherapy Treatment Options for Patients With Cancer: A Pharmacy Perspective

    In this episode, listen to Kelly Romo, PharmD, BCOP; and Shauna Kraft, PharmD, BCOP, share their takeaways from a live webinar on available emerging subcutaneous immunotherapy options for patients with cancer including: Basic mechanism of action and role of hyaluronidase in subcutaneous immunotherapy formulation and available dosing/schedulesAvailable pharmacodynamics/pharmacokinetics, efficacy, and safety data for subcutaneous immunotherapy formulationsCurrent and potential models for administration of subcutaneous immunotherapy in the inpatient setting and day-to-day considerationsPresenters: Kelly Romo, PharmD, BCOP Manager, Oncology Medical Drug Management and Customer Initiatives Blue Cross Blue Shield Michigan Detroit, Michigan Shawna Kraft, PharmD, BCOP Clinical Pharmacist, Specialist Michigan Medicine, Rogel Cancer Center Clinical Associate Professor University of Michigan College of Pharmacy Ann Arbor, Michigan Resources: Consolidate your learning with a recording from an on-demand webcast, download the slides associated with this discussion, or read an expert text module or commentary on this topic.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    25 min
  2. What Oncology Pharmacists Need to Know About ADCs in Solid Tumor Management

    06/27/2025

    What Oncology Pharmacists Need to Know About ADCs in Solid Tumor Management

    In this episode, hear Allison Butts, PharmD, BCOP and Danielle Roman, PharmD, BCOP, share their insights on the best practices for incorporating antibody–drug conjugates (ADCs) into clinical practice including: An overview of ADC structure and mechanism of actionA topline review of data supporting the current FDA-approved indications for ADCs targeting HER2 and TROP-2 across multiple tumor typesAn in-depth look at common and serious adverse events with each approved ADC along with an overview of management strategiesEditor’s note: On June 23, 2025, the FDA granted accelerated approval for a new indication for datopotamab deruxtecan, one of the antibody drug conjugates discussed in this podcast. Datopotamab deruxtecan is now also approved for adults with locally advanced or metastatic EGFR-mutated NSCLC who have received previous EGFR-targeted therapy and platinum-based chemotherapy.  Program faculty: Allison Butts, PharmD, BCOP Pharmacist Manager, Oncology Clinical Pharmacist, Breast Oncology UK HealthCare Markey Cancer Center Lexington, Kentucky Danielle Roman, PharmD, BCOP Manager, Oncology Clinical Pharmacy Services Allegheny Health Network Pittsburgh, Pennsylvania Program page: https://bit.ly/4lr7cT6 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    34 min
  3. Innovations in NCFBE: Understanding the Patient Burden and Best Practices in Diagnostics

    06/18/2025

    Innovations in NCFBE: Understanding the Patient Burden and Best Practices in Diagnostics

    In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including: The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection)Cough as the most significant symptom and burdenImaging bronchiectasis with classic and inflammatory findingsDifferentiating the causes of NCFBE to inform patient carePresenters Brett M. Elicker, MD Professor of Clinical Radiology Chief, Cardiothoracic Imaging Division Department of Radiology & Biomedical Imaging University of California, San Francisco San Francisco, California David E. Griffith, MD, ATSF, FACCP, FRSM Professor of Medicine Division of Mycobacterial and Respiratory Diseases Department of Medicine National Jewish Health Denver, Colorado Program page:  https://bit.ly/4mZbYsm Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    24 min
  4. Systemic Mastocytosis: Pharmacist-Focused Strategies to Improve Patient Outcomes

    05/16/2025

    Systemic Mastocytosis: Pharmacist-Focused Strategies to Improve Patient Outcomes

    Listen in as Jonathan A. Bernstein, MD, and Ryan Haumschild, PharmD, MS, MBA, CPEL, discuss how to manage the multidisciplinary care of patients with systemic mastocytosis (SM) from both the allergy/immunology and pharmacy perspective, including: Strategies to better identify patients presenting with features of SM to facilitate timely diagnosisCurrent guideline-recommended treatment approachesEmerging data on new targeted agents for SMPharmacist-led strategies to help patients achieve better outcomes (e.g., specialist referral, polypharmacy counseling, and anaphylaxis education)Presenters Jonathan A. Bernstein, MD Professor of Medicine Division of Rheumatology, Allergy and Immunology Department of Internal Medicine University of Cincinnati College of Medicine Partner Advanced Allergy Services, LLC Partner Bernstein Clinical Research Center, LLC Cincinnati, Ohio Ryan Haumschild, PharmD, MS, MBA, CPEL Vice President of Pharmacy, Ambulatory Emory Healthcare Winship Cancer Institute Atlanta, Georgia Full link to program page: https://bit.ly/3HcA8z2 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    31 min
  5. How Pharmacists Can Enhance Comprehensive Patient-Centered Care for Patients With HR+/HER2- MBC and Comorbidities

    04/29/2025

    How Pharmacists Can Enhance Comprehensive Patient-Centered Care for Patients With HR+/HER2- MBC and Comorbidities

    In this podcast episode, Allison Butts, PharmD, BCOP, reviews how pharmacists can help in providing comprehensive patient-centric care for patients with HR+/HER2- MBC and preexisting comorbid conditions, including: Common comorbidities and complexities in managing patients with HR+/HER2- MBCTreatment landscape for patients with HR+/HER2- MBCReal-world studies in women with HR+/HER2- MBCMitigation and management of drug interactions and multidisciplinary team coordination treatment selectionPatient goals and coordinating with multidisciplinary team to maximize quality of lifeLink to full program: https://bit.ly/4jCQe38 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    17 min
  6. Navigating Immune-Related Toxicities: Insights on Monitoring, Treatment, and Prevention

    01/10/2025

    Navigating Immune-Related Toxicities: Insights on Monitoring, Treatment, and Prevention

    In this episode, Alexa Basilio, PharmD, BCOP and Jessica Davis, PharmD, BCOP, CPP discuss immune-related adverse events and toxicities among patients using immune checkpoint inhibitors. This overview will include discussion about:  How and when to monitor and treat mild vs severe immune-related toxicitiesThe art of balancing and tapering low-dose and high-dose corticosteroidsDifferentiating between immune-related and chemotherapy- or targeted therapy–associated adverse events for optimal management approachesInvolvement of multidisciplinary teams early during treatment to prevent immune-related adverse eventsImportance of educating patients, caregivers, and providers on immune-related toxicities Presenters:  Alexa Basilio, PharmD, BCOP University of Florida College of Pharmacy  Oncology Pharmacy Specialist  McKesson, The US Oncology Network Tampa, Florida  Jessica Davis, PharmD, BCOP, CPP  Levine Cancer Institute Clinical Pharmacist Coordinator, Adult Hematology/Oncology Atrium Health Levine Center Charlotte, North Carolina  Link to full program:  https://bit.ly/3We4HJy Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    30 min
  7. How Primary Care Providers Can Expand Their Role in HBV Management

    04/26/2024

    How Primary Care Providers Can Expand Their Role in HBV Management

    In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to: Engage key stakeholders in the provision of HBV care​Provide HBV management resources to support PCPs who are doing screening​Consider specialty and primary care collaborations that empower PCPs with clear guidance on how to manage patients living with HBVPresenters: Su Wang, MD, MPH, FACP Medical Director Center for Asian Health and Viral Hepatitis Programs Cooperman Barnabas Medical Center RWJBarnabas-Rutgers Medical Group Associate Member Health Care Policy and Aging Research The Rutgers Institute for Health Senior Advisor Global Health, Hepatitis B Foundation Florham Park, New Jersey Richard R. Andrews, MD, MPH President, Houston Viral Hepatitis Task Force Former Co-Chair, National Task Force on Hepatitis B Board-Certified Family Medicine Addiction Medicine Physician Houston, Texas Ruth Brogden, MPH Patient Advocate Amy S. Tang, MD Former Co-Chair, National Task Force on Hepatitis B Director of Immigrant Health North East Medical Services San Francisco, California Link to full program:  https://bit.ly/3TuqFHI Link to the slides: https://bit.ly/44hXpHu Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    19 min
  8. How to Implement Earlier Hepatitis B Treatment

    03/26/2024

    How to Implement Earlier Hepatitis B Treatment

    In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Patient subgroups to consider for treatment outside guideline criteriaAdverse event and cost-effectiveness considerationsIntegration of patient perspectives in wider treatmentPresenters: Mark S. Sulkowski, MD, FIDSA, FAASLD Professor of Medicine Director, Division of Infectious Diseases, Johns Hopkins Bayview Medical Center Johns Hopkins University School of Medicine Baltimore, Maryland Tatyana Kushner, MD, MSCE Associate Professor Division of Liver Diseases Icahn School of Medicine at Mount Sinai New York, New York Paul Y. Kwo, MD Professor of Medicine Director of Hepatology Stanford University School of Medicine Palo Alto, California Jacki Chen, PhD Patient Advocate  Link to full program:  https://bit.ly/3TuqFHI Link to the slides: https://bit.ly/4a60GM4 Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    21 min
See All (23)

About

Enhance your pharmacy practice with ProCE’s up-to-date, clinically relevant, and evidence-based education across a variety of therapeutic areas.

Information